Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natus Medical Inc    BABY

Delayed Quote. Delayed  - 08/25 09:58:05 pm
38.37 USD   -0.70%
07/20 Natus Medical Announces Record Second Quarter 2016 Financial Resu..
07/20 NATUS MEDICAL : beats 2Q profit forecasts
07/06 Natus Medical Acquires RetCam Ophthalmic Imaging System
News SummaryMost relevantAll newsSector news 

Natus Medical Inc : Natus Medical to Hold 2012 First Quarter Financial Results Conference Call on April 26

share with twitter share with LinkedIn share with facebook
share via e-mail
04/17/2012 | 01:05pm CEST

Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company intends to release its 2012 first quarter financial results before the market opens on Thursday, April 26, 2012. Natus management will host an investment-community conference call the same day beginning at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) to discuss those results and to answer questions.

Individuals interested in listening to the conference call may do so by dialing 888-268-4176 for domestic callers, or 1-617-597-5493 for international callers, and entering reservation code 32875965. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 888-286-8010 for domestic callers, or 1-617-801-6888 for international callers, and entering reservation code 56980616.

The conference call also will be available real-time via the Internet at http://investor.natus.com, and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.

About Natus Medical Incorporated

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories.

Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, 650-802-0400
Vice President and Chief Financial Officer

© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on NATUS MEDICAL INC
08/03 NATUS MEDICAL : Management's Discussion and Analysis of Financial Condition and ..
07/20 Natus Medical Announces Record Second Quarter 2016 Financial Results
07/20 NATUS MEDICAL : beats 2Q profit forecasts
07/20 NATUS MEDICAL INC : Results of Operations and Financial Condition, Financial Sta..
07/06 Natus Medical Acquires RetCam Ophthalmic Imaging System
07/06 Natus Medical to Hold 2016 Second Quarter Financial Results Conference Call o..
06/29 IRADIMED CORPORATION Announces Appointment of Jonathan Kennedy to its Board o..
06/28 NATUS MEDICAL : Announces $20 Million Share Repurchase Program
06/28 NATUS MEDICAL : to Present at Jefferies 2016 Healthcare Conference
06/11 NATUS MEDICAL : $107,984 Federal Contract Awarded to Natus Medical
More news
Sector news : Advanced Medical Equipment & Technology - NEC
08/17DJAGILENT TECHNOLOGIES : Tech Tapers Annual Outlook Amid Slowing Life Sciences Sal..
08/15DJFisher & Paykel Files Patent Infringement Claim Against ResMed
08/02DJCERNER : Edges Annual Revenue Guidance Lower
07/29DJSony Reports Surprise Profit
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
07/20 Natus Medical's (BABY) CEO Jim Hawkins on Q2 2016 Results - Earnings Call Tra..
07/20 Natus Medical Q2 revenues up 5%; Non-GAAP EPS up 15%; updates guidance
07/20 Natus Medical beats by $0.03, beats on revenue
07/19 Notable earnings before Wednesday?s open
06/03 Natus Medical expands share buybacks $20M
Financials ($)
Sales 2016 389 M
EBIT 2016 71,4 M
Net income 2016 46,9 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 27,21
P/E ratio 2017 23,85
Capi. / Sales 2016 3,27x
Capi. / Sales 2017 3,12x
Capitalization 1 273 M
More Financials
Duration : Period :
Natus Medical Inc Technical Analysis Chart | BABY | US6390501038 | 4-Traders
Full-screen chart
Technical analysis trends NATUS MEDICAL INC
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 45,0 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
James B. Hawkins President, Chief Executive Officer & Director
Robert A. Gunst Chairman
Jonathan A. Kennedy CFO, Principal Financial & Accounting Officer, SVP
D. Christopher Chung VP-Medical Affairs, Quality & Regulatory
Doris E. Engibous Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PHILIPS8.53%27 818
ILLUMINA, INC.-11.67%24 855
More Results